| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 11/13/2013 | CN102134197B Green synthesis method for schiff base compounds |
| 11/13/2013 | CN101918386B 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides |
| 11/13/2013 | CN101560398B Tetrahydrofuran compound, liquid crystal composition and liquid crystal display device containing the liquid crystal composition |
| 11/07/2013 | US20130298291 Cyanoenamines and Their use as Fungicides |
| 11/07/2013 | US20130296421 Arylpropionyl-alpha-pyrone antibacterial agents |
| 11/07/2013 | US20130296414 1-Phenyl-2-Dimethylaminomethyl Cyclohexane Compounds And Therapies For Depressive Symptoms, Pain and Incontinence |
| 11/07/2013 | US20130296332 1h-quinazoline-2,4-diones |
| 11/07/2013 | US20130296295 Bcl-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 11/06/2013 | EP2660239A1 Chemical compounds as synthetic intermediates |
| 11/06/2013 | EP2658851A1 Heterocyclic compounds suitable for the treatment of dyslipidemia |
| 11/06/2013 | CN102532081B Phomalactone and Musacin metabolite and application thereof |
| 11/06/2013 | CN102336734B Method for catalytic oxidation preparation of lactone from cycloalkane |
| 11/06/2013 | CN102099350B Novel herbicides |
| 10/31/2013 | WO2013161851A1 Benzamide derivative |
| 10/31/2013 | WO2013160418A1 Novel compounds |
| 10/31/2013 | WO2013159224A1 2-carbamo(thio)yl-1,3- dioxopropyl derivatives in cancer therapy |
| 10/31/2013 | US20130289117 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 10/31/2013 | US20130289003 Diazeniumdiolate heterocyclic derivatives |
| 10/30/2013 | EP2655353A1 Derivatives of glyco-cf2-serine and glyco-cf2-threonine |
| 10/30/2013 | EP2655343A1 Polymorphs of 3-chloro-4[(2r)-2 |
| 10/30/2013 | EP2655323A1 Ingenol-3-acylates iii and ingenol-3-carbamates |
| 10/30/2013 | CN103373979A Catalytic reaction method for producing lactones |
| 10/30/2013 | CN103373978A Reaction method for preparing corresponding lactone, hydroxy acid and dicarboxylic acid through cyclic ketone oxidation |
| 10/30/2013 | CN103373977A Oxidation reaction method of cyclic ketone compound |
| 10/30/2013 | CN103373975A Oxidation method of cycloparaffin |
| 10/30/2013 | CN101133010B Process and intermediate compounds useful in preparation of statins |
| 10/29/2013 | US8569362 Polyketide molecules as anticancer agents |
| 10/29/2013 | CA2690229C Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| 10/24/2013 | WO2013158302A1 Derivatives of docosahexaenoylethanolamide and uses thereof |
| 10/24/2013 | WO2013130792A3 Prodrugs of fluorinated mevalonates to inhibit the mevalonate pathway of streptococcus pneumoniae |
| 10/24/2013 | US20130281393 Materials and methods for prevention and treatment of viral infections |
| 10/24/2013 | US20130281366 Heterocyclic compounds suitable for the treatment of dyslipidemia |
| 10/23/2013 | CN103360357A A simvastatin-gliclazide co-amorphous compound |
| 10/22/2013 | US8563754 Compounds, compositions and methods for preventing skin darkening |
| 10/22/2013 | US8563736 Amide derivatives, process for preparation thereof and use thereof as insecticide |
| 10/17/2013 | WO2013152848A1 Glycomimetics as pseudomonas aeruginosa lectin inhibitors |
| 10/17/2013 | WO2013152476A1 Process for the preparation of benzylbenzene sglt2 inhibitors |
| 10/16/2013 | EP2650289A1 Glycomimetics as pseudomonas Aeruginosa lectin inhibitors |
| 10/16/2013 | EP2648689A2 2-pyrones |
| 10/16/2013 | CN103354807A Cyanoenamines and their use as fungicides |
| 10/16/2013 | CN103351275A Liquid crystal compound including polyfluoroindan, composition thereof and application |
| 10/15/2013 | CA2592170C Glycine derivative and use thereof |
| 10/10/2013 | US20130267586 Compound |
| 10/09/2013 | EP2646451A2 Heptose derivatives for use in the treatment of bacterial infections |
| 10/09/2013 | CN102112461B Novel diaryl hepatonoid compound and use thereof |
| 10/08/2013 | US8552204 Zinc cluster |
| 10/08/2013 | US8552056 Biologically active taxane analogs and methods of treatment by oral administration |
| 10/08/2013 | US8552054 Anticancer agents, viricides, psychological disorders |
| 10/08/2013 | US8552033 Inhibitors of CXCR2 |
| 10/05/2013 | CA2811812A1 Procedure for the purification of tiacumicin b |
| 10/03/2013 | WO2013147096A1 Isotope-labeled pyrylium compound |
| 10/03/2013 | WO2013146539A1 Ppars agonist activity enhancing drug |
| 10/03/2013 | WO2013144394A1 Materials for selective recognition of alternaria mycotoxins (alternariol and alternariol monomethyl ether) |
| 10/03/2013 | US20130261175 2-pyrones |
| 10/02/2013 | CN103333146A Liquid crystal compounds containing 2-alkyltetrahydropyrane structure, and preparation method and application thereof |
| 10/02/2013 | CN102432573B Method for preparing lovastatin |
| 10/01/2013 | US8546591 Method for producing cis-rose oxide |
| 10/01/2013 | CA2681545C Fluorinated derivatives of deferiprone |
| 09/26/2013 | WO2013142812A1 Antibacterial agents: sidechain-fluorinated myxopyronin derivatives |
| 09/26/2013 | US20130252811 Novel herbicide |
| 09/25/2013 | EP2640693A1 Cyanoenamines and their use as fungicides |
| 09/25/2013 | CN103328460A Derivatives of glyco-CF2-serine and glyco-CF2-threonine |
| 09/25/2013 | CN103319445A Crystal structure of SGLT2 inhibitor and preparation method of crystal structure |
| 09/25/2013 | CN103319444A Liquid crystal compound containing 4-tetrahydropyran structure and preparation method and application thereof |
| 09/19/2013 | US20130245284 Prodrugs of Fluorinated Mevalonates to Inhibit the Mevalonate Pathway of Streptococcus pneumoniae |
| 09/19/2013 | US20130245130 Natural product antibiotics and analogs thereof |
| 09/18/2013 | CN103304529A Preparation method and application of triterpenoid with immunosuppressive activity |
| 09/17/2013 | US8536349 Cyclic ethers |
| 09/12/2013 | WO2013134415A1 Mannose derivatives for treating bacterial infections |
| 09/12/2013 | US20130237595 Antibacterial agents: high-potency myxopyronin derivatives |
| 09/11/2013 | EP2636665A1 Method for producing ester |
| 09/11/2013 | CN103298799A Heterocyclic compounds suitable for the treatment of dyslipidemia |
| 09/11/2013 | CN103288790A Preparation method and application of triterpenoid with effect of resisting rheumatoid arthritis |
| 09/11/2013 | CN103288789A Preparation method of fully-acylated glycal |
| 09/11/2013 | CN103288788A Delta-valerolactone compounds, preparation method and application |
| 09/10/2013 | US8530677 Substituted 3-hydroxy-delta-lactones from epoxides |
| 09/06/2013 | WO2013130792A2 Prodrugs of fluorinated mevalonates to inhibit the mevalonate pathway of streptococcus pneumoniae |
| 09/04/2013 | EP2632255A1 Diazeniumdiolate heterocyclic derivatives |
| 09/04/2013 | CN103274883A Method for preparing lactone through catalyzing oxidation of ketone compound |
| 09/04/2013 | CN102391229B Ethyl maltol chlorination continuous production method and device |
| 09/04/2013 | CN102381951B Cyclohexanone-contained mono-carbonyl analogues of curcumin and usage thereof |
| 09/04/2013 | CN101993428B Method for purifying ethyl maltol |
| 09/04/2013 | CN101679339B Method for manufacturing neuraminic acid derivatives |
| 09/04/2013 | CN101486664B Polysubstituted five membered ring small molecular compound used as influenza virus neuraminidase inhibitor |
| 09/03/2013 | US8524909 Tetrahydro-pyran derivatives |
| 08/28/2013 | CN103265515A Sibiraea angustata acid a, stereoisomer and applications thereof |
| 08/27/2013 | US8519164 Process and intermediate compounds useful in the preparation of statins |
| 08/27/2013 | US8519159 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6-disubstituted pyran derivatives |
| 08/27/2013 | CA2599843C Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 08/22/2013 | US20130217900 Chiral intermediates useful for the preparation of hydroxyphosphine ligands |
| 08/22/2013 | US20130217898 Method for manufacturing ester |
| 08/22/2013 | US20130217762 Selective Androgen Receptor Modulators |
| 08/21/2013 | EP2628737A1 Hypocholesterolemic, anti-inflammatory and antiepileptic neuroprotective compound |
| 08/21/2013 | EP2627646A1 Compound |
| 08/21/2013 | CN102260235B Raw material against influenza A virus as well as preparation and coating |
| 08/21/2013 | CN101928226B N-(2-ethoxy) feriilamidoethyl nitrate compound and preparation method thereof |
| 08/21/2013 | CN101851244B Substituted phenyl keto enols as pesticides and herbicides |
| 08/20/2013 | US8513268 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy |
| 08/15/2013 | US20130211098 Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds |
| 08/14/2013 | CN103249709A Esters of O-substituted hydroxy carboxylic acids and preparations thereof |